Apic Bio Competitors and Similar CompaniesClear all
Apic Bio's competitors and similar companies include FinVector, Selonterra, Stoke Therapeutics and Grindeks.
 Apic Bio Apic Bio is a gene therapy company developing novel treatment options for patients with rare genetic diseases. |  Selonterra Selonterra is a company that develops therapeutics for Alzheimer's and Parkinson's diseases. |  Stoke Therapeutics Stoke Therapeutics is a developer of antisense oligonucleotide medicines that target ribonucleic acid (RNA) splicing to enhance gene expression for the treatment of genetic diseases. |  Grindeks Grindeks, a pharmaceutical company, engages in the research, development, manufacture, and sale of generics and active pharmaceutical ingredients. | ||
Founding Date | Founding Date 2017 | Founding Date 2013 | Founding Date 2017 | Founding Date 2014 | Founding Date 1991 |
Type | Type Private | Type Private | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Cambridge, US HQ Cambridge, US | Locations Kuopio, FI HQ | Locations San Mateo, US HQ | Locations Bedford, US HQ Cambridge, US | |
Employees | Employees 6 | Employees 338 | Employees 3 | Employees 1106% decrease | Employees 1,505 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $184.4m (FY, 2025) | Revenue (est.) €141.4m (FY, 2019) |
Net income | Net income N/A | Net income N/A | Net income N/A | Net income ($6.9m) (FY, 2025) | Net income €13.5m (FY, 2019) |
Funding | |||||
Total funding raised | Total funding raised $ 51m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 130m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
FinVector
HQ
Kuopio, FI
Employees
338
FinVector is a company engaged in the research and development of gene and cell therapies.
View companySelonterra
HQ
San Mateo, US
Employees
3
Selonterra is a company that develops therapeutics for Alzheimer's and Parkinson's diseases.
View companyStoke Therapeutics
HQ
Bedford, US
Employees
110↓ 6% decrease
Stoke Therapeutics is a developer of antisense oligonucleotide medicines that target ribonucleic acid (RNA) splicing to enhance gene expression for the treatment of genetic diseases.
View companyGrindeks
HQ
Rīga, LV
Employees
1,505
Grindeks, a pharmaceutical company, engages in the research, development, manufacture, and sale of generics and active pharmaceutical ingredients.
View company